ZNF2
gene geneOn this page
Also known as A1-5ZNF661Zfp661
Summary
ZNF2 (zinc finger protein 2, HGNC:12991) is a protein-coding gene on chromosome 2q11.1, encoding Zinc finger protein 2 (Q9BSG1). May be involved in transcriptional regulation.
The protein encoded by this gene belongs to the C2H2-type zinc-finger protein family. The exact function of this gene is not known, however, zinc-finger proteins are known to interact with DNA and function as transcription regulators. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 7549 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 19 total
- MANE Select transcript:
NM_021088
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12991 |
| Approved symbol | ZNF2 |
| Name | zinc finger protein 2 |
| Location | 2q11.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | A1-5, ZNF661, Zfp661 |
| Ensembl gene | ENSG00000275111 |
| Ensembl biotype | protein_coding |
| OMIM | 194500 |
| Entrez | 7549 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000611147, ENST00000611463, ENST00000614034, ENST00000617923, ENST00000622059, ENST00000876804
RefSeq mRNA: 5 — MANE Select: NM_021088
NM_001017396, NM_001282398, NM_001291604, NM_001291605, NM_021088
CCDS: CCDS42712, CCDS42713, CCDS62957, CCDS77434, CCDS77435
Canonical transcript exons
ENST00000614034 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003712550 | 95181103 | 95184317 |
| ENSE00003715158 | 95176188 | 95176259 |
| ENSE00003726469 | 95177483 | 95177609 |
| ENSE00003734368 | 95180159 | 95180272 |
| ENSE00003749171 | 95165809 | 95165860 |
Expression profiles
Bgee: expression breadth ubiquitous, 189 present calls, max score 82.69.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.8723 / max 44.3196, expressed in 1599 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 21416 | 3.7768 | 1587 |
| 21417 | 0.0955 | 32 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.69 | gold quality |
| secondary oocyte | CL:0000655 | 82.48 | gold quality |
| endothelial cell | CL:0000115 | 79.67 | gold quality |
| oocyte | CL:0000023 | 78.96 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.77 | gold quality |
| ileal mucosa | UBERON:0000331 | 78.44 | gold quality |
| pancreatic ductal cell | CL:0002079 | 75.37 | silver quality |
| stromal cell of endometrium | CL:0002255 | 75.10 | gold quality |
| granulocyte | CL:0000094 | 74.85 | gold quality |
| islet of Langerhans | UBERON:0000006 | 74.46 | gold quality |
| cortical plate | UBERON:0005343 | 74.27 | gold quality |
| ganglionic eminence | UBERON:0004023 | 74.20 | gold quality |
| ventricular zone | UBERON:0003053 | 73.41 | gold quality |
| tibialis anterior | UBERON:0001385 | 72.66 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 72.15 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 71.39 | gold quality |
| muscle of leg | UBERON:0001383 | 70.85 | gold quality |
| gastrocnemius | UBERON:0001388 | 70.59 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 70.29 | gold quality |
| right adrenal gland | UBERON:0001233 | 70.21 | gold quality |
| apex of heart | UBERON:0002098 | 70.17 | gold quality |
| left adrenal gland | UBERON:0001234 | 69.93 | gold quality |
| sperm | CL:0000019 | 69.62 | silver quality |
| prefrontal cortex | UBERON:0000451 | 69.47 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 69.45 | gold quality |
| leukocyte | CL:0000738 | 68.97 | gold quality |
| adrenal gland | UBERON:0002369 | 68.89 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 68.55 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 68.52 | gold quality |
| adrenal cortex | UBERON:0001235 | 68.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.69 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| SULT1A1 |
miRNA regulators (miRDB)
90 targeting ZNF2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-302A-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302B-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302C-3P | 99.89 | 71.20 | 1778 |
| HSA-MIR-302D-3P | 99.89 | 71.25 | 1777 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-373-3P | 99.84 | 70.68 | 1668 |
| HSA-MIR-520E-3P | 99.84 | 70.55 | 1698 |
| HSA-MIR-3663-3P | 99.84 | 70.39 | 798 |
| HSA-MIR-372-3P | 99.83 | 70.58 | 1691 |
| HSA-MIR-520A-3P | 99.83 | 70.59 | 1687 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp661 | ENSMUSG00000034800 |
| rattus_norvegicus | LOC100909998 | ENSRNOG00000068677 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 2 — Q9BSG1 (reviewed: Q9BSG1)
Alternative names: Zinc finger protein 2.2, Zinc finger protein 661
All UniProt accessions (3): Q9BSG1, A0A087WYR5, Q68CY6
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BSG1-2 | 2 | yes |
| Q9BSG1-3 | 3 | |
| Q9BSG1-4 | 4 |
RefSeq proteins (5): NP_001017396, NP_001269327, NP_001278533, NP_001278534, NP_066574* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050758 | Znf_C2H2-type | Family |
Pfam: PF00096, PF01352
UniProt features (20 total): zinc finger region 9, sequence conflict 3, region of interest 2, compositionally biased region 2, splice variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BSG1-F1 | 74.43 | 0.47 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 48 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN, GTGCCTT_MIR506, CREB_Q3, chr2q11, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF, BARX1_TARGET_GENES, DACH1_TARGET_GENES, DIDO1_TARGET_GENES, HES4_TARGET_GENES, NFE2L1_TARGET_GENES, ZBTB18_TARGET_GENES, ZNF563_TARGET_GENES, ZNF618_TARGET_GENES
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (4): DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
616 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF2 | CNBP | P20694 | 723 |
| ZNF2 | KMT2C | Q8NEZ4 | 642 |
| ZNF2 | MBNL2 | Q5VZF2 | 572 |
| ZNF2 | MBNL3 | Q9NUK0 | 565 |
| ZNF2 | MBNL1 | Q9NR56 | 512 |
| ZNF2 | MAT2A | P31153 | 480 |
| ZNF2 | PUM1 | Q14671 | 446 |
| ZNF2 | SLC7A8 | Q9UHI5 | 425 |
| ZNF2 | CRBN | Q96SW2 | 404 |
| ZNF2 | GPD1 | P21695 | 372 |
| ZNF2 | GLIS2 | Q9BZE0 | 360 |
| ZNF2 | CLCN1 | P35523 | 355 |
| ZNF2 | PAXIP1 | Q6ZW49 | 340 |
| ZNF2 | DMPK | Q09013 | 334 |
| ZNF2 | YIPF2 | Q9BWQ6 | 321 |
| ZNF2 | TBRG4 | Q969Z0 | 321 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DVL3 | ZNF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM41 | ZNF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN2 | ZNF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | ZNF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF2 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF2 | PRMT5 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF2 | TRIM24 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF2 | APOBEC3DE | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF2 | DVL3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF2 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPANXN2 | ZNF2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (122): TSGA10 (Two-hybrid), KRTAP10-7 (Two-hybrid), ZNF2 (Affinity Capture-MS), ZNF2 (Reconstituted Complex), KIAA0020 (Affinity Capture-MS), ZFP62 (Affinity Capture-MS), TAF1B (Affinity Capture-MS), ZNF800 (Affinity Capture-MS), RRP8 (Affinity Capture-MS), BUD13 (Affinity Capture-MS), RPF2 (Affinity Capture-MS), ZNF770 (Affinity Capture-MS), GLYR1 (Affinity Capture-MS), RPL37A (Affinity Capture-MS), DDX10 (Affinity Capture-MS)
ESM2 similar proteins: A2A761, A2T7D2, A3KN32, A3KN36, A7MBI1, B2RXC5, E9PYI1, O43296, P0CG31, P10072, P10078, P17023, P17097, P18725, P18728, P52738, Q02525, Q07231, Q0VCB0, Q12901, Q14592, Q49AA0, Q4V8A8, Q571J5, Q5CZA5, Q5JNZ3, Q5R7I8, Q5RB33, Q5RBX0, Q5RBY9, Q61967, Q62396, Q6PF04, Q6ZNG0, Q6ZS27, Q7Z398, Q80YP6, Q8BIQ3, Q8IZ26, Q96N20
Diamond homologs: A0JPL0, A1L1L7, A2A761, A2VDP4, A3KN36, A6QLU5, A6QPT6, A7MBI1, A8MT65, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, O95780, P10076, P17014, P17023, P17025, P17030, P17032, P17098, P51523, P51814, P52736, P52742, P58317, Q02975, Q06730, Q06732, Q08DG8, Q0VCB0, Q13360, Q14584, Q14587, Q14590, Q147U1, Q16587, Q29RZ4, Q2M218
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
19 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 12 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
833 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:95177570:G:GT | donor_gain | 1.0000 |
| 2:95165839:TCCC:T | donor_gain | 0.9900 |
| 2:95165858:G:GT | donor_gain | 0.9900 |
| 2:95177481:A:AG | acceptor_gain | 0.9900 |
| 2:95177481:A:AT | acceptor_loss | 0.9900 |
| 2:95177481:AG:A | acceptor_gain | 0.9900 |
| 2:95177482:G:GG | acceptor_gain | 0.9900 |
| 2:95177482:GG:G | acceptor_gain | 0.9900 |
| 2:95177576:A:AG | donor_loss | 0.9900 |
| 2:95177607:TGGGT:T | donor_loss | 0.9900 |
| 2:95177608:GG:G | donor_gain | 0.9900 |
| 2:95177609:GG:G | donor_gain | 0.9900 |
| 2:95177610:G:GA | donor_loss | 0.9900 |
| 2:95177611:T:G | donor_loss | 0.9900 |
| 2:95181101:A:AG | acceptor_gain | 0.9900 |
| 2:95181102:G:GG | acceptor_gain | 0.9900 |
| 2:95181102:GACT:G | acceptor_gain | 0.9900 |
| 2:95165858:GAGG:G | donor_loss | 0.9800 |
| 2:95165859:AG:A | donor_loss | 0.9800 |
| 2:95165860:GG:G | donor_loss | 0.9800 |
| 2:95166018:A:T | donor_gain | 0.9800 |
| 2:95170178:A:T | donor_gain | 0.9800 |
| 2:95177482:GGA:G | acceptor_gain | 0.9800 |
| 2:95177610:G:GG | donor_gain | 0.9800 |
| 2:95181101:AGACT:A | acceptor_gain | 0.9800 |
| 2:95181102:GACTG:G | acceptor_gain | 0.9800 |
| 2:95170177:G:GT | donor_gain | 0.9700 |
| 2:95177616:G:T | donor_gain | 0.9700 |
| 2:95180243:A:T | donor_gain | 0.9700 |
| 2:95165737:G:GT | donor_gain | 0.9600 |
AlphaMissense
2806 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:95181960:T:C | F378L | 0.998 |
| 2:95181962:T:A | F378L | 0.998 |
| 2:95181962:T:G | F378L | 0.998 |
| 2:95181624:T:C | F266L | 0.997 |
| 2:95181626:T:A | F266L | 0.997 |
| 2:95181626:T:G | F266L | 0.997 |
| 2:95181708:T:C | F294L | 0.997 |
| 2:95181710:T:A | F294L | 0.997 |
| 2:95181710:T:G | F294L | 0.997 |
| 2:95181792:T:C | F322L | 0.997 |
| 2:95181794:C:A | F322L | 0.997 |
| 2:95181794:C:G | F322L | 0.997 |
| 2:95181456:T:C | F210L | 0.996 |
| 2:95181458:C:A | F210L | 0.996 |
| 2:95181458:C:G | F210L | 0.996 |
| 2:95181574:G:C | R249P | 0.996 |
| 2:95181643:T:C | L272P | 0.996 |
| 2:95181597:T:C | F257L | 0.995 |
| 2:95181599:T:A | F257L | 0.995 |
| 2:95181599:T:G | F257L | 0.995 |
| 2:95181639:T:C | S271P | 0.995 |
| 2:95181653:C:A | H275Q | 0.995 |
| 2:95181653:C:G | H275Q | 0.995 |
| 2:95181733:G:C | R302P | 0.995 |
| 2:95181876:T:C | F350L | 0.995 |
| 2:95181878:C:A | F350L | 0.995 |
| 2:95181878:C:G | F350L | 0.995 |
| 2:95181540:T:C | F238L | 0.994 |
| 2:95181542:C:A | F238L | 0.994 |
| 2:95181542:C:G | F238L | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000000009 (2:95169763 A>G), RS1000276023 (2:95183192 G>A), RS1000562308 (2:95170049 C>T), RS1000983508 (2:95175552 A>G), RS1001410772 (2:95168290 T>C), RS1001530780 (2:95178152 TAG>T), RS1001553788 (2:95184705 G>T), RS1001646757 (2:95178420 T>A), RS1001830513 (2:95171547 TA>T), RS1001836086 (2:95184256 G>A), RS1001945366 (2:95165069 T>C), RS1002435775 (2:95182732 A>T), RS1002580297 (2:95168172 A>G,T), RS1003208028 (2:95179328 G>A), RS1003317588 (2:95179617 T>A)
Disease associations
OMIM: gene MIM:194500 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 2 |
| Arsenic | affects methylation, affects cotreatment, increases abundance, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| bisphenol F | increases expression, affects cotreatment | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, increases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| resorcinol | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| bisphenol S | affects cotreatment, increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| T-2 Toxin | increases expression | 1 |
| Testosterone | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW16 | HEK293 eGFP-ZNF2 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.